Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Thyroid Neoplasms × Digoxin × Endocrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Endocrine 1

Conditions

Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1

Interventions

Paclitaxel 7 Magnetic Resonance Spectroscopy 5 vandetanib 4 selpercatinib 4 Iodine-131 4 Fluorodeoxyglucose F18 4 fosbretabulin 3 dabrafenib 3 Vemurafenib 3 Sunitinib 3 Sorafenib 3 trametinib 2 tipifarnib 2 pembrolizumab 2 pazopanib 2 combretastatin 2 cabozantinib 2 Trastuzumab 2 Specimen Handling 2 Nivolumab 2 Gefitinib 2 FAPI-46 2 Everolimus 2 Carboplatin 2 Bortezomib 2 AZD 6244 2 tumor necrosis factor-alpha, CNGRC fusion protein, human 1 tremelimumab 1 tanespimycin 1 spartalizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05507775 2024-04-11

DIGUP-TC

Radboud University Medical Center

Phase NA Completed

EndocrineHead & Neck

Thyroid Cancer, Papillary, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡